Aquatic birds
Mallard duck (Anas platyrhynchos)
| Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Lab |
|---|---|---|---|---|---|---|---|---|
| CRUDE OILS | no effect | body weight; body and skin temperature at 16C; mean heat production and thermal conductance at 16C | Not Reported | Adult | 5/dose | Toxicity Factor Datasets | Laboratory | |
| CRUDE OILS | increase | body temperature at an ambient temperature of -17C, compared to control | Not Reported | Adult | 5/dose | Toxicity Factor Datasets | Laboratory |
| Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Lab |
|---|---|---|---|---|---|---|---|---|
| CRUDE OILS | increase @ 1% and 3% | hepatic microsomal naphthalene metabolism (nmol/min/mg protein), compared to control, in adult females and in neonatal ducklings hatched from eggs laid by females (1% Prudhoe Bay dose level was not significantly different for neonates). | Female | Adult | 6 adults/dose; 5-20 neonates/dose | Toxicity Factor Datasets | Laboratory |
| Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Age-Specific | Lab |
|---|---|---|---|---|---|---|---|---|---|
| CRUDE OILS | decrease @ 3% | plasma corticosterone concentration, compared to control | Male | Juvenile | 24/dose | Toxicity Factor Datasets | 18 wks | Laboratory | |
| CRUDE OILS | increase @ 3% | body weight | Male | Juvenile | Not Reported | Toxicity Factor Datasets | 18 wks | Laboratory | |
| CRUDE OILS | increase @ 1 and 3% | daily food intake rate | Male | Juvenile | Not Reported | Toxicity Factor Datasets | 18 wks | Laboratory | |
| CRUDE OILS | decrease @ 0.5, 1, 3% | plasma corticosterone concentration, compared to control | Male | Juvenile | Not Reported | Toxicity Factor Datasets | 18 wks | Laboratory | |
| CRUDE OILS | decrease @ 0.5% | plasma corticosterone concentration, compared to control | Male | Juvenile | Not Reported | Toxicity Factor Datasets | 18 wks | Laboratory | |
| CRUDE OILS | increase @ 0.5, 1, 3% | hepatic microsomal naphthalene metabolism (nmol/min/mg protein) | Male | Juvenile | Not Reported | Toxicity Factor Datasets | 18 wks | Laboratory |
| Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Age-Specific | Lab |
|---|---|---|---|---|---|---|---|---|---|
| BORIC ACID | decrease @ 1600 ppm | growth rate measured as changes in body weight, compared to control | Both Male and Female | Juvenile | 10 animals/pen; 3 pens/dose | Toxicity Factor Datasets | 1 d | Laboratory | |
| BORIC ACID | decrease @ 1600 ppm | hematocrit and hemoglobin concentration, compared to controls | Both Male and Female | Juvenile | 10 animals/pen; 3 pens/dose | Toxicity Factor Datasets | 1 d | Laboratory | |
| BORIC ACID | increase @ 100, 400, 1600 ppm | plasma triglyceride concentration (21-42% increase, compared to controls) | Both Male and Female | Juvenile | 10 animals/pen; 3 pens/dose | Toxicity Factor Datasets | 1 d | Laboratory | |
| BORIC ACID | increase @ 1600 ppm | plasma calcium concentration (6-10% greater than controls) and brain acetylcholinestrase activity (umol/min/g) | Both Male and Female | Juvenile | 10 animals/pen; 3 pens/dose | Toxicity Factor Datasets | 1 d | Laboratory | |
| BORIC ACID | 2 ug/g @ control; 4 ug/g @ 100 ppm; 5 ug/g @ 400 ppm; 51 ug/g @ 1600 ppm | boron accumulation in brain (geometric mean; ug/g dry weight) | Both Male and Female | Juvenile | 10 animals/pen; 3 pens/dose | Toxicity Factor Datasets | 1 d | Laboratory | |
| BORIC ACID | decrease @ 400 and 1600 ppm | brain ATP (nmol/g) and protein (mg/g) concentrations | Both Male and Female | Juvenile | 10 animals/pen; 3 pens/dose | Toxicity Factor Datasets | 1 d | Laboratory | |
| BORIC ACID | 1 ug/g @ controls; 3 ug/g @ 100 ppm; 3 ug/g @ 400 ppm; 29 ug/g @ 1600 ppm | liver boron concentration (geometric mean; ug/g dry weight) | Both Male and Female | Juvenile | 10 animals/pen; 3 pens/dose | Toxicity Factor Datasets | 1 d | Laboratory |
| Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Lab |
|---|---|---|---|---|---|---|---|---|
| BORIC ACID | decrease @ 1000 ppm | % hatching success in fertile eggs and productivity per female (mean # of 21 d old ducklings) | Both Male and Female | Adult | 15/sex/dose | Toxicity Factor Datasets | Laboratory | |
| BORIC ACID | no effect | eggshell thickness and Ratcliffe index of eggshell quality | Female | Adult | 15/dose | Toxicity Factor Datasets | Laboratory | |
| BORIC ACID | increase @ 1000 ppm | % embryo mortality (day 15 to hatch) and duckling mortality (hatch to day 7) | Both Male and Female | Both Adults and Juveniles | 11-23/dose | Toxicity Factor Datasets | Laboratory | |
| BORIC ACID | decrease @ 300, 1000 ppm | body weight of hatchlings, compared to controls | Both Male and Female | Hatchling | 11-23/dose | Toxicity Factor Datasets | Laboratory | |
| BORIC ACID | decrease @ 30, 300, 1000 ppm | hatchling weight gain over 21 d, compared to controls | Both Male and Female | Hatchling | 11-23/dose | Toxicity Factor Datasets | Laboratory | |
| BORIC ACID | Egg; 3 ug/g @ 30 ppm, 13 ug/g @ 300 ppm, 49 ug/g @ 1000 ppm: Liver; 15 ug/g @ 300 ppm, 33 ug/g @ 1000 ppm: Brain; 14 ug/g @ 300 ppm, 41 ug/g @ 1000 ppm | boron concentrations in adult tissues (geometric mean; ug/g dry weight). | Both Male and Female | Adult | 10-20/dose | Toxicity Factor Datasets | Laboratory | |
| BORIC ACID | Liver; 3 ug/g @ 30 ppm, 17 ug/g @ 300 ppm, 51 ug/g @ 1000 ppm: Brain; 4 ug/g @ 30 ppm, 19 ug/g @ 300 ppm, 66 ug/g @ 1000 ppm | boron concentrations in ducklings 21 d of age (geometric mean; ug/g dry weight). Concentrations at other doses were not detected. | Both Male and Female | Juvenile | 10-13/dose | Toxicity Factor Datasets | Laboratory |
| Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Lab |
|---|---|---|---|---|---|---|---|---|
| CRUDE OILS | no effect | % mortality, compared to controls | Male | Adult | 5/dose | Toxicity Factor Datasets | Laboratory | |
| CRUDE OILS | no effect | body weight, gross lesions or signs of clinical illness, compared to controls | Male | Adult | 5/dose | Toxicity Factor Datasets | Laboratory | |
| FUEL OILS | no effect | body weight and gross lesion incidence, compared to controls | Male | Adult | 4-5/dose | Toxicity Factor Datasets | Laboratory | |
| FUEL OILS | decrease @ 4.0, 7.0, 12.0 ml/kg/d | mean spleen index (spleen wt./body wt.) | Male | Adult | 4-5/dose | Toxicity Factor Datasets | Laboratory | |
| COREXIT 9527 | no effect | % mortality, compared to controls | Male | Adult | 6/dose | Toxicity Factor Datasets | Laboratory | |
| COREXIT 9527 | no effect | body weight, compared to controls | Male | Adult | 6/dose | Toxicity Factor Datasets | Laboratory | |
| FUEL OILS | increase @ 2.5, 4.0 ml/kg | susceptibility to Pasturella multocida estimated as % mortality 2-wks post-exposure to Pasturella multocida which was given on day 28 | Male | Adult | 9-32/dose | Toxicity Factor Datasets | Laboratory | |
| CRUDE OILS | increase @ 4.0 ml/kg | susceptibility to Pasturella multocida estimated as % mortality 2-wks post-exposure to Pasturella multocida which was given on day 28 | Male | Adult | 10-32/dose | Toxicity Factor Datasets | Laboratory | |
| CRUDE OILS, FUEL OILS | no effect | antibody-mediated immunity estimated by direct spleen plaque-forming cell assays (PFCs/g spleen); mallards inoculated with sheep red blood cells on day 24 | Male | Adult | 9/dose | Toxicity Factor Datasets | Laboratory |
| Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Age-Specific | Lab |
|---|---|---|---|---|---|---|---|---|---|
| CRUDE OILS | no effect | body weight | Not Reported | Juvenile | 25/dose | Toxicity Factor Datasets | 4 d | Laboratory | |
| CRUDE OILS | increase | plasma triglyceride and sodium concentrations, compared to control (based on treatment means at 3, 6, 9 wks) | Not Reported | Juvenile | 25/dose | Toxicity Factor Datasets | 4 d | Laboratory | |
| CRUDE OILS | decrease | hematocrit and plasma cholesterol concentration, compared to control (based on treatment means at 3, 6, 9 wks) | Not Reported | Juvenile | 25/dose | Toxicity Factor Datasets | 4 d | Laboratory | |
| COREXIT 9527 | no effect | body weight | Not Reported | Juvenile | 25/dose | Toxicity Factor Datasets | 4 d | Laboratory | |
| COREXIT 9527 | increase | plasma alanine aminotransferase activity, compared to control | Not Reported | Juvenile | 25/dose | Toxicity Factor Datasets | 4 d | Laboratory |
| Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Age-Specific | Lab |
|---|---|---|---|---|---|---|---|---|---|
| FUEL OILS | decrease @ 5, 10, 20, 50 ul | 6-day % survival of mallard embryos from eggs treated on the 8th day of incubation | Not Reported | Embryo | 50/dose | Toxicity Factor Datasets | 8d of incubation | Laboratory | |
| FUEL OILS | decrease @ 5, 10, 20, 50 ul | 30-d % hatching success | Not Reported | Embryo | 50/dose | Toxicity Factor Datasets | 8d of incubation | Laboratory |
| Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Age-Specific | Lab |
|---|---|---|---|---|---|---|---|---|---|
| CRUDE OILS | decrease @ 1, 5, 10 ul | 18-d % survival, mean embryonic weight, crown-rump length (5ul) and bill length | Both Male and Female | Embryo | 50/dose | Toxicity Factor Datasets | 1d of development | Laboratory | |
| CRUDE OILS | increase @ 1, 5 ul | % abnormal survivors, compared to controls | Both Male and Female | Embryo | 50/dose | Toxicity Factor Datasets | 1d of development | Laboratory |
| Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Lab |
|---|---|---|---|---|---|---|---|---|
| CRUDE OILS | no effect | onset of laying, egg production, egg fertility, compared to controls | Female | Adult | 20 hens/dose | Toxicity Factor Datasets | Laboratory | |
| CRUDE OILS | decrease | egg hatchability (# eggs hatching/# fertile eggs), compared to controls | Female | Adult | 20 hens/dose | Toxicity Factor Datasets | Laboratory | |
| DDE (4,4'-) | no effect | onset of laying, egg production, egg fertility and egg hatchability, compared to controls | Female | Adult | 20 hens/dose | Toxicity Factor Datasets | Laboratory |
| Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Age-Specific | Lab |
|---|---|---|---|---|---|---|---|---|---|
| POLYCYCLIC AROMATIC HYDROCARBONS (PAHs) | increase @ 0.2, 2.0 mg/kg egg | embryonic mortality, compared to controls | Not Reported | Embryo | 22/dose | Toxicity Factor Datasets | 5 d of incubation | Laboratory | |
| BENZO[k]FLUORANTHENE | increase @ 0.2, 2.0 mg/kg egg | embryo mortality, compared to controls | Not Reported | Embryo | 20/dose | Toxicity Factor Datasets | 5 d of incubation | Laboratory |
| Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Lab |
|---|---|---|---|---|---|---|---|---|
| ALUMINUM SULFATE | decrease @ 0.5% | body weight, average daily weight gain and tibiotarsus length, compared to controls | Not Reported | Juvenile | 8/dose | Toxicity Factor Datasets | Laboratory | |
| ALUMINUM SULFATE | 3.59 ppm dry wt @ control, 5.16 ppm @ 0.1%, 15.52 ppm @ 0.05% | liver aluminum concentrations (ppm, dry wt) in ducklings | Not Reported | Juvenile | 8/dose | Toxicity Factor Datasets | Laboratory | |
| ALUMINUM SULFATE | no effect | plasma growth hormone and insulin-like growth factor-I concentrations | Not Reported | Juvenile | 8/dose | Toxicity Factor Datasets | Laboratory |
| Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Lab |
|---|---|---|---|---|---|---|---|---|
| SEWAGE SLUDGE | no effect | immune defenses; resistance to Pasturella multocida estimated by % mortality 14 d after challenge, compared to controls | Male | Adult | 10/dose | Toxicity Factor Datasets | Laboratory | |
| SEWAGE SLUDGE | increase @ 20% Milorganite or Metrogro | liver cadmium concentrations; compared to controls | Male | Adult | 10/dose | Toxicity Factor Datasets | Laboratory |
| Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Age-Specific | Lab |
|---|---|---|---|---|---|---|---|---|---|
| TRIMETHYLTIN CHLORIDE | increase @ 5, 50 ppm | % mortality (100% mortality within 5 d for 50 ppm dose), compared to controls | Not Reported | Juvenile | 5/dose | Toxicity Factor Datasets | 3-4 d | Laboratory | |
| TRIMETHYLTIN CHLORIDE | increase @ 50 ppm | incidence of mild to marked degeneration of neurons of the pons, medulla oblongata, gray matter of the spinal cord and pyrimidal cells of the cerebral cortex; mild to moderate lympoid depletion of spleen and thymus; atrophy of myofibers in skeletal and ca | Not Reported | Juvenile | 5/dose | Toxicity Factor Datasets | 3-4 d | Laboratory | |
| TRIMETHYLTIN CHLORIDE | 17% decrease @ 5 ppm | body weight | Not Reported | 5/dose | Toxicity Factor Datasets | 3-4 d | Laboratory | ||
| TRIMETHYLTIN CHLORIDE | increase @ 5 ppm | cephalic tumor incidence | Not Reported | Juvenile | 5/dose | Toxicity Factor Datasets | 3-4 d | Laboratory | |
| TRIETHYLTIN CHLORIDE | no effect | % mortality, compared to controls | Not Reported | Juvenile | 5/dose | Toxicity Factor Datasets | 3-4 d | Laboratory |
| Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Lab |
|---|---|---|---|---|---|---|---|---|
| PHOSPHORUS (YELLOW OR WHITE) | 6.96 mg/kg bw (2.66-8.96 95% CI) | 24 hour median lethal dose | Female | Adult | 6 birds/dose | Toxicity Factor Datasets | Laboratory | |
| PHOSPHORUS (YELLOW OR WHITE) | 6.46 mg/kg bw (5.19-7.69 95% CI) | 24 hour median lethal dose | Male | Adult | 4-5 birds/dose | Toxicity Factor Datasets | Laboratory | |
| PHOSPHORUS (YELLOW OR WHITE) | 3.90 mg/kg bw (3.24-4.69 95% CI) | 24 hour median lethal dose | Female | Adult | 4-5 birds/dose | Toxicity Factor Datasets | Laboratory | |
| PHOSPHORUS (YELLOW OR WHITE) | reduced above 6.2 mg/kg bw | body weight versus controls | Not Reported | Adult | 4-5 birds/dose | Toxicity Factor Datasets | Laboratory | |
| PHOSPHORUS (YELLOW OR WHITE) | increased above 4.3 mg/kg bw | liver to body weight ratio versus controls | Not Reported | Adult | 4-5 birds/dose | Toxicity Factor Datasets | Laboratory | |
| PHOSPHORUS (YELLOW OR WHITE) | positive relationship | relation between liver to body weight ratio and dose | Male | Adult | 4-5 birds/dose | Toxicity Factor Datasets | Laboratory | |
| PHOSPHORUS (YELLOW OR WHITE) | positive correlation | relation between dose and frequency and severity of hepatic and kidney lesions | Not Reported | Adult | 4-5 birds/dose | Toxicity Factor Datasets | Laboratory | |
| PHOSPHORUS (YELLOW OR WHITE) | positive correlation | P4 concentration in fat versus dose | Male | Adult | 4-5 birds/dose | Toxicity Factor Datasets | Laboratory |
| Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Lab |
|---|---|---|---|---|---|---|---|---|
| PHOSPHORUS (YELLOW OR WHITE) | increased @ 484.2, 972.0 ug/g diet (nominal concentrations) | incidence of mortality versus controls | Both Male and Female | Adult | 5 males, 5 females/dose | Toxicity Factor Datasets | Laboratory | |
| PHOSPHORUS (YELLOW OR WHITE) | increased @ 235.0, 484.2, 972.0 ug/g (nominal concentrations) | incidence of clinical signs versus controls | Both Male and Female | Adult | 5 males, 5 females/dose | Toxicity Factor Datasets | Laboratory | |
| PHOSPHORUS (YELLOW OR WHITE) | decreased @ 484.2, 972.0 ug/g (nominal concentrations) | food consumption during first week of treatment versus controls | Both Male and Female | Adult | 5 males, 5 females/dose | Toxicity Factor Datasets | Laboratory | |
| PHOSPHORUS (YELLOW OR WHITE) | decreased @ 235.0, 484.2, 972.0 ug/g (nominal concentrations) | body weight versus controls | Both Male and Female | Adult | 5 males, 5 females/dose | Toxicity Factor Datasets | Laboratory | |
| PHOSPHORUS (YELLOW OR WHITE) | 91.1 ug/g | No Observable Effect Level, based on mortality, pathology, clinical signs | Both Male and Female | Adult | 5 males, 5 females/dose | Toxicity Factor Datasets | Laboratory | |
| PHOSPHORUS (YELLOW OR WHITE) | 679.8 ug/g (194.3-442.6 95% CI ) | LC50 | Both Male and Female | Adult | 5 males, 5 females/dose | Toxicity Factor Datasets | Laboratory |
| Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type |
|---|---|---|---|---|---|---|---|
| DDE (4,4'-), DIELDRIN, OXYCHLORDANE, POLYCHLORINATED BIPHENYLS | positive correlation | relationships between EROD activity and dieldrin concentrations | Female | Adult | 5 birds/timepoint (timepoints = 0,10,20,32,42,52,59,70,80,90,100 days) | Bloomington | Toxicity Factor Datasets |
| DDE (4,4'-), DIELDRIN, OXYCHLORDANE, POLYCHLORINATED BIPHENYLS | positive correlation | relationship between BROD, PROD, and EROD activities and total PCB, oxychlordane, and TEQs concentrations | Female | Adult | 5 birds/timepoint (timepoints = 0,10,20,32,42,52,59,70,80,90,100 days) | Bloomington | Toxicity Factor Datasets |
| Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Age-Specific | Lab |
|---|---|---|---|---|---|---|---|---|---|
| AROCLOR 1254 | increased @ 100, 250, 500 mg/kg bw | thyroid wt/body wt and liver wt/body wt ratios versus controls | Male | Adult | 6-12/dose | Toxicity Factor Datasets | 1-2 yr | Laboratory | |
| AROCLOR 1254 | increased @ 20,100, 250, 500 mg/kg bw | hepatic microsomal EROD and PROD activities versus controls | Male | Adult | 6-12/dose | Toxicity Factor Datasets | 1-2 yr | Laboratory | |
| AROCLOR 1254 | decreased @ 20, 100, 250, 500 mg/kg bw | plasma triiodothyronine concentrations versus controls | Male | Adult | 6-12/dose | Toxicity Factor Datasets | 1-2 yr | Laboratory | |
| AROCLOR 1254 | no effect | leukocyte counts, plasma biochemistry, corticosterone concentration versus controls | Male | Adult | 6-12/dose | Toxicity Factor Datasets | 1-2 yr | Laboratory | |
| AROCLOR 1254 | increased @ 250, 500 mg/kg bw | lymphocyte proliferation to PHA versus controls | Male | Adult | 6-12/dose | Toxicity Factor Datasets | 1-2 yr | Laboratory |
| Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Lab |
|---|---|---|---|---|---|---|---|---|
| AROCLOR 1254 | no effect | reproductive success or nest attentiveness versus controls | Both Male and Female | Adult | 22 pairs | Toxicity Factor Datasets | Laboratory | |
| AROCLOR 1254 | no effect | body and liver weights of parents and offspring versus controls | Both Male and Female | Both Adults and Juveniles | 22 pairs | Toxicity Factor Datasets | Laboratory | |
| AROCLOR 1254 | 55-65 ppm | range of wet wt concentrations of Aroclor 1254 in adult carcasses | Both Male and Female | Adult | 22 pairs | Toxicity Factor Datasets | Laboratory | |
| AROCLOR 1254 | 29.5(1.4) ppm | mean(SE) wet wt concentrations of Aroclor 1254 in carcasses of 3 week old ducklings | Not Reported | Juvenile | 10 | Toxicity Factor Datasets | Laboratory | |
| AROCLOR 1254 | 23.3(1.0) ppm | mean(SE) wet wt concentrations of Aroclor 1254 in eggs | Not Reported | Embryo | 19 eggs | Toxicity Factor Datasets | Laboratory |
| Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type |
|---|---|---|---|---|---|---|---|
| GLYPHOSATE | increased @ 50, 90 percent | population density 2 years post-spray versus controls | Not Reported | Not Reported | 3-6 sample wetlands/treatment | near Lakota (48deg03'N, 98deg21'W) | Toxicity Factor Datasets |
| Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Lab |
|---|---|---|---|---|---|---|---|---|
| SELENITE, SODIUM | figure/table | figures and tables of selenium concentration over time (% of administered dose) | Female | Adult | Not Reported | Toxicity Factor Datasets | Laboratory |
| Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Age-Specific | Lab |
|---|---|---|---|---|---|---|---|---|---|
| EMAMECTIN BENZOATE | no effect | numbers of eggs laid and hatched, eggshell thickness, and 14-day hatchling survival versus controls | Both Male and Female | Both Adults and Juveniles | 16 pairs/group | Toxicity Factor Datasets | 22 weeks | Laboratory | |
| EMAMECTIN BENZOATE | no effect | mortality versus controls | Both Male and Female | Adult | 16 pairs/group | Toxicity Factor Datasets | 22 weeks | Laboratory | |
| EMAMECTIN BENZOATE | no effect | incidence of signs of toxicity and body weight versus controls | Both Male and Female | Adult | 16 pairs/group | Toxicity Factor Datasets | 22 weeks | Laboratory | |
| EMAMECTIN BENZOATE | no effect | feed consumption versus controls | Both Male and Female | Adult | 16 pairs/group | Toxicity Factor Datasets | 22 weeks | Laboratory | |
| EMAMECTIN BENZOATE | no effect | microscopic changes to brain, spinal cord, or peripheral nerves versus controls | Both Male and Female | Adult | 16 pairs/group | Toxicity Factor Datasets | 22 weeks | Laboratory |
| Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Age-Specific | Lab |
|---|---|---|---|---|---|---|---|---|---|
| EMAMECTIN BENZOATE | 76 mg/kg bw, 56-102 (95% CI) | acute oral LD50 | Both Male and Female | Adult | 10/dose | Toxicity Factor Datasets | 19 weeks | Laboratory | |
| EMAMECTIN BENZOATE | < 25 mg/kg bw | no-observed-effect level, based on body weight loss | Both Male and Female | Adult | 10/dose | Toxicity Factor Datasets | 19 weeks | Laboratory | |
| EMAMECTIN BENZOATE | 570 ppm diet, 391-915 (95% CI) | dietary LC50 | Both Male and Female | Juvenile | 10/dose | Toxicity Factor Datasets | 10 days | Laboratory | |
| EMAMECTIN BENZOATE | 20 ppm diet | no-observed-effect concentration (NOEC), based on reduced feed consumption and weight gain | Both Male and Female | Juvenile | 10/dose | Toxicity Factor Datasets | 10 days | Laboratory |
| Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Age-Specific | Lab |
|---|---|---|---|---|---|---|---|---|---|
| SELENOMETHIONINE | no effect | histological changes to nervous system, bones, feathers, feather follicles, claws and scaled skin versus controls | Male | Adult | 21/dose | Toxicity Factor Datasets | 14 mo | Laboratory | |
| SELENOMETHIONINE | increased in birds that died, and in some 40 ppm survivors | histological changes to skin (loss of fat), muscle, liver, pancreas, kidney, lymph nodes, spleen, seminiferous tubules | Male | Adult | 21/dose | Toxicity Factor Datasets | 14 mo | Laboratory |
| Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | Age-Specific | Lab |
|---|---|---|---|---|---|---|---|---|---|
| SELENOMETHIONINE | increased @ 80 ppm | mortality versus controls | Male | Adult | 21/dose | Toxicity Factor Datasets | 1 yr | Laboratory | |
| SELENOMETHIONINE | decreased @ 80 ppm | feed consumption over time versus controls | Male | Adult | 21/dose | Toxicity Factor Datasets | 1 yr | Laboratory | |
| SELENOMETHIONINE | decreased @ 40 and 80 ppm | body weight over exposure period versus controls | Male | Adult | 21/dose | Toxicity Factor Datasets | 1 yr | Laboratory | |
| SELENOMETHIONINE | increased in birds that died | incidence of macroscopic abnormalities versus controls | Male | Adult | 21/dose | Toxicity Factor Datasets | 1 yr | Laboratory | |
| SELENOMETHIONINE | increased @ 40 ppm | incidence of macroscopic abnormalities of muscles, claws and feathers versus controls | Male | Adult | 21/dose | Toxicity Factor Datasets | 1 yr | Laboratory |